Suppr超能文献

吲哚美辛长期用于安胎的安全性与有效性

Safety and efficacy of long-term tocolysis with indomethacin.

作者信息

Gerson A, Abbasi S, Johnson A, Kalchbrenner M, Ashmead G, Bolognese R

机构信息

Section of Perinatology, Pennsylvania Hospital, Philadelphia.

出版信息

Am J Perinatol. 1990 Jan;7(1):71-4. doi: 10.1055/s-2007-999450.

Abstract

Indomethacin was utilized in 24 pregnancies (31 exposed fetuses) in preterm labor who labored despite intravenous tocolysis. The mean gestational age at the start of indomethacin therapy was 25.1 weeks (+/- 4.4), mean duration of indomethacin therapy was 43.9 days (+/- 31.4), mean gestational age at delivery 33.1 weeks (+/- 3.7). Neonatal follow-up revealed the same incidence of complications in these indomethacin-exposed infants, when they were compared with all other infants born in the same time period and exposed to intravenous tocolytics only when matched for gestational age at delivery.

摘要

在24例早产且尽管接受静脉内宫缩抑制治疗仍继续分娩的孕妇(31例暴露胎儿)中使用了吲哚美辛。吲哚美辛治疗开始时的平均孕周为25.1周(±4.4),吲哚美辛治疗的平均持续时间为43.9天(±31.4),分娩时的平均孕周为33.1周(±3.7)。新生儿随访显示,与同期出生且仅在分娩时孕周匹配时接受静脉内宫缩抑制剂治疗的所有其他婴儿相比,这些暴露于吲哚美辛的婴儿并发症发生率相同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验